End of
Translation

Data released for once-daily guanfacine extended release trial in children with ADHD
Shire – November 16, 2006 — Shire plc (Nasdaq: SHPGY, LSE: SHP, TSX: SHQ) announced today that once-daily doses of the investigational medication guanfacine extended release (GXR, also referred to as SPD503), a selective alpha-2A-adrenoceptor agonist, significantly improved symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in […]

New Free Brochure on Key Nutrients for a Healthy Pregnancy, including Brain Nutrient Choline
PRNewswire — Some expectant mothers believe being pregnant is a license to consume whatever they crave. But, the quality of calories consumed is important to ensure the mother’s health and the baby’s growth and development.
“Moms-to-be should choose nutrient-rich foods like eggs, low-fat […]

Shorter wear time provides shorter duration of effect
October 2006 — Shire announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. […]

October 2006 – PRNewswire - Since 1999, Tishcon Corp. has
donated to Vitamin Relief USA (VRUSA) a continuous stream of high quality
multivitamin/minerals. Just last year Tishcon’s donation exceeded over 14
million children’s chewables. These multi’s are distributed to
undernourished children through hundreds of organizations, agencies and
schools across the country. After three years of receiving daily vitamins,
one school in […]

Two percent of children have Obstructive Sleep Apnea, a disorder associated with neuropsychological deficits and neuronal brain injury
Symptomatic childhood sleep-disordered breathing includes a range of conditions in which children have difficulties with breathing when they are asleep. The conditions range from simple snoring to the most severe condition, obstructive sleep apnea (OSA). In children, OSA […]

A new study just released testing the prescription ADHD medications Concerta and Adderall XR in teenage driving might still not give us a definitive answer.  The design of the study described below tested the drivers only after the time that the effects of the 8 hour slow release Adderall XR would be expected to wear off, […]